New Delhi, India

Rana Pratap Singh

This inventor holds 1 USPTO granted patent. Top assignees: Jawaharlal Nehru University, Stellenbosch University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rana Pratap Singh. Retrieved from https://idiyas.com/inventor/rana-pratap-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rana Pratap Singh: Inventor in Cancer Research

Introduction

Rana Pratap Singh is an inventor associated with New Delhi, India. His patent work concerns compounds based on fisetin and their potential use in cancer treatment. The supplied information also lists Stellenbosch University and Jawaharlal Nehru University among the organizations with which he has worked.

Latest Patents

The provided data identifies one patent associated with Singh: 4′-Substituted Analogues of Fisetin and Their Use in the Treatment of Cancer. The invention describes fisetin analogues with a ring-deactivating group at the 4′ position on the B-ring, characterized by a para-Hammett constant greater than zero. It concerns the use of these compounds to treat cancer, including epithelial cancers. The supplied information lists 1 patent.

Career Highlights

Singh’s listed affiliations include Stellenbosch University and Jawaharlal Nehru University. His patent reflects research focused on chemical compounds and their potential therapeutic applications.

Collaborations

The supplied information names Catherine Hart Kaschula and Arpit Dheeraj as Singh’s coworkers. Their listed connection provides context for the collaborative research associated with his work.

Conclusion

Rana Pratap Singh’s identified patent centers on 4′-substituted fisetin analogues and their proposed application in cancer treatment, including epithelial cancers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…